Nomura Holdings
SLNO

Nomura Holdings’s Soleno Therapeutics SLNO Stock Holding History

Nomura Holdings’s Portfolio SLNO Stock Details SLNO Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2025
Q2 		– Sell
-30,000
Closed -$2.14M – 1898
2025
Q1 		$2.14M Buy
+30,000
New +$1.46M ﹤0.01% 1032

Other funds holding SLNO

Janus Henderson Group
Janus Henderson Group London, United Kingdom $209B AUM 37.72% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
ACA
Avoro Capital Advisors New York $10.2B AUM 149.19% 1-Year Est. Return
VCM
Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM
NCM
Nantahala Capital Management New Canaan, Connecticut $2.72B AUM 121.58% 1-Year Est. Return
PCH
Polar Capital Holdings London, United Kingdom $28.2B AUM 115.26% 1-Year Est. Return
KCM
Khrom Capital Management Miami Beach, Florida $1.09B AUM 14.82% 1-Year Est. Return

Nomura Holdings's SLNO Position: Q3 2025 in Review

Nomura Holdings sold out of Soleno Therapeutics (SLNO) in Q3 2025, closing a stake of 3,644 shares — an estimated $305K sold.

Nomura Holdings first reported a position in SLNO in Q1 2025 and held it in 2 quarters. The position peaked at $1.68M in Q1 2025. 240 funds tracked by Wall St. Rank hold SLNO as of Q3 2025.

  • Nomura Holdings reported no remaining Soleno Therapeutics position as of Q3 2025 after selling out during the quarter.
  • Nomura Holdings sold 3,644 Soleno Therapeutics shares in Q3 2025, an estimated $305K.
  • Nomura Holdings first reported a position in Soleno Therapeutics in Q1 2025 and held it in 2 quarters.
  • Nomura Holdings's Soleno Therapeutics position peaked at $1.68M in Q1 2025.
  • 240 funds tracked by Wall St. Rank held Soleno Therapeutics as of Q3 2025.

Based on Nomura Holdings's 13F filing for Q3 2025, filed 14 Nov 2025.